OTC Pharmaceuticals in India

Product Code DAT02659
Publication Date November 2010
Publisher Datamonitor
Product Type Report
Pages 45
ISBN Number not applicable

OTC Pharmaceuticals in India

Datamonitor's OTC Pharmaceuticals in India industry profile is an essential resource for top-level data and analysis covering the OTC Pharmaceuticals industry. It includes data on market size and segmentation, plus textual and graphical analysis of the key trends and competitive landscape, leading companies and demographic information.

Scope

  • Contains an executive summary and data on value, volume and/or segmentation
  • Provides textual analysis of OTC Pharmaceuticals in India's recent performance and future prospects
  • Incorporates in-depth five forces competitive environment analysis and scorecards
  • Includes a five-year forecast of OTC Pharmaceuticals in India
  • The leading companies are profiled with supporting key financial metrics
  • Supported by the key macroeconomic and demographic data affecting the market

Highlights

  • Detailed information is included on market size, measured by both value and volume
  • Five forces scorecards provide an accessible yet in depth view of the market's competitive landscape
  • Market shares are covered by manufacturer and/or brand
  • Also features market breakdown by distribution channel

Why you should buy this report

  • Spot future trends and developments
  • Inform your business decisions
  • Add weight to presentations and marketing materials
  • Save time carrying out entry-level research

Market Definition

The OTC pharmaceuticals market consists of the retail sale of traditional medicines, cough and cold preparations (tablets, mixtures, lozenges, topical remedies, inhalers), vitamins and minerals (multi-vitamins, single minerals, single vitamins, tonics, cod liver oil), indigestion preparations (tablets, powders, mixtures), analgesics (Paracetamol, Ibuprofen, Aspirinand other analgesics), and medicated skin products (anti-bacteria's, acne treatments, anti-fungal, disinfectants and other), topical OTC medicines (anesthetic products, anti-itch products, antibiotic creams/gels), plasters & bandages (adhesive bandages/plasters, first aid tape, gauze pads/rolled gauze, liquid bandages and other tape or bandage), first aid kits and other (anti-smoking aids, rectal medications, eye/ear drops, sleeping aids, and motion sickness).

For the purposes of this report, Asia-Pacific comprises Australia, China, India, Japan, Singapore, South Korea, and Taiwan.

Contents

  • Executive Summary
  • Market Overview
    • Market Definition
    • Research Highlights
    • Market Analysis
  • Market Value
  • Market Segmentation I
  • Market Segmentation II
  • Market Share
  • Five Forces Analysis
    • Summary
    • Buyer Power
    • Supplier Power
    • New Entrants
    • Substitutes
    • Rivalry
  • Leading Companies
    • Cipla Ltd
    • Johnson & Johnson
    • Glaxosmithkline Plc
  • Market Distribution
  • Market Forecasts
    • Market Value Forecast
  • Macroeconomic Indicators
  • Appendix
    • Methodology
    • Industry Associations
    • Related Datamonitor Research
    • Disclaimer
  • About Datamonitor
    • Premium Reports
    • Summary Reports
    • Datamonitor Consulting
  • List of Tables
    • Table 1: India Otc Pharmaceuticals Market Value: $ Million, 2005-09
    • Table 2: India Otc Pharmaceuticals Market Segmentation I:% Share, by Value, 2009
    • Table 3: India Otc Pharmaceuticals Market Segmentation II: % Share, by Value, 2009
    • Table 4: India Otc Pharmaceuticals Market Share: % Share, by Value, 2009
    • Table 5: Cipla Ltd: Key Facts
    • Table 6: Cipla Ltd: Key Financials ($)
    • Table 7: Cipla Ltd: Key Financials (Rs.)
    • Table 8: Cipla Ltd: Key Financial Ratios
    • Table 9: Johnson & Johnson: Key Facts
    • Table 10: Johnson & Johnson: Key Financials ($)
    • Table 11: Johnson & Johnson: Key Financial Ratios
    • Table 12: Glaxosmithkline Plc: Key Facts
    • Table 13: Glaxosmithkline Plc: Key Financials ($)
    • Table 14: Glaxosmithkline Plc: Key Financials (£)
    • Table 15: Glaxosmithkline Plc: Key Financial Ratios
    • Table 16: India Otc Pharmaceuticals Market Distribution: % Share, by Value, 2009
    • Table 17: India Otc Pharmaceuticals Market Value Forecast: $ Million, 2009-14
    • Table 18: India Size of Population (Million), 2005-09
    • Table 19: India Gdp (Constant 2000 Prices, $ Billion), 2005-09
    • Table 20: India Gdp (Current Prices, $ Billion), 2005-09
    • Table 21: India Inflation, 2005-09
    • Table 22: India Consumer Price Index (Absolute), 2005-09
    • Table 23: India Exchange Rate, 2005-09
  • List of Figures
    • Figure 1: India Otc Pharmaceuticals Market Value: $ Million, 2005-09
    • Figure 2: India Otc Pharmaceuticals Market Segmentation I:% Share, by Value, 2009
    • Figure 3: India Otc Pharmaceuticals Market Segmentation II: % Share, by Value, 2009
    • Figure 4: India Otc Pharmaceuticals Market Share: % Share, by Value, 2009
    • Figure 5: Forces Driving Competition in The Otc Pharmaceuticals Market in India, 2009
    • Figure 6: Drivers of Buyer Power in The Otc Pharmaceuticals Market in India, 2009
    • Figure 7: Drivers of Supplier Power in The Otc Pharmaceuticals Market in India, 2009
    • Figure 8: Factors Influencing The Likelihood of New Entrants in The Otc Pharmaceuticals Market in India, 2009
    • Figure 9: Factors Influencing The Threat of Substitutes in The Otc Pharmaceuticals Market in India, 2009
    • Figure 10: Drivers of Degree of Rivalry in The Otc Pharmaceuticals Market in India, 2009
    • Figure 11: Cipla Ltd: Revenues & Profitability
    • Figure 12: Cipla Ltd: Assets & Liabilities
    • Figure 13: Johnson & Johnson: Revenues & Profitability
    • Figure 14: Johnson & Johnson: Assets & Liabilities
    • Figure 15: Glaxosmithkline Plc: Revenues & Profitability
    • Figure 16: Glaxosmithkline Plc: Assets & Liabilities
    • Figure 17: India Otc Pharmaceuticals Market Distribution: % Share, by Value, 2009
    • Figure 18: India Otc Pharmaceuticals Market Value Forecast: $ Million, 2009-14